Dr. Elizabeth Lipke is the Mary and John H. Sanders Professor of Chemical Engineering at Auburn University’s Samuel Ginn College of Engineering. Her lab focuses on tissue engineering, particularly in cancer and cardiovascular systems, with a focus on 3D in vitro models for drug screening and disease mechanisms. She leads interdisciplinary research combining biomaterials, microfluidics, and stem cell technologies to model complex biological systems. Education & Affiliations: PhD in Chemical Engineering (assumed based on role) Director of the Lipke Lab at Auburn University Collaborator with Dr. Arnold (cancer biology) and Dr. Mistriotis (biomedical engineering) Research Interests: Engineered cancer models to study obesity-related colorectal cancer progression Cardiac tissue engineering using pluripotent stem cells Microfluidic platforms for scalable production of hydrogel microspheres Drug efficacy testing in vascularized tumor models Awards & Recognition: 2024 AIMBE College of Fellows Inductee (top 2% in medical/biological engineering) NSF Grant ($621,934) for cardiac tissue manufacturing research (2018) Alabama Launchpad $25,000 award for Vivosphere technology (2023) Lab Highlights: Developed tumor-mimetic microvascular platforms for anti-cancer drug screening Engineered insulin-sensitive/insulin-resistant colorectal cancer models Pioneered scalable production of cardiac tissue microspheres from hiPSCs Grants & Funding: NSF RECODE Grant (2021) LAUNCH Innovation Grant (2023) Labs/Teams: Lipke Lab at Auburn University Collaborations with Arnold Lab (cancer biology) and Mistriotis Lab (biomedical engineering)











